Kryzhanovskaya Ludmila

Kryzhanovskaya Ludmila is an experienced medical professional currently serving as Executive Medical Director at Intercept Pharmaceuticals since June 2020. Prior to this role, Kryzhanovskaya held the position of Sr. Medical Director, MSPV, SERM at Sage Therapeutics from February 2018 to April 2020, and worked as a Pharmacovigilance Medical Director Consultant. Earlier experience includes a significant tenure at Eli Lilly and Company from October 2001 to December 2017, where Kryzhanovskaya progressed through various roles, including Medical Fellow, Medical Fellow I, and Sr. Clinical Research Physician/Medical Advisor.